Recombinant Myosin 9 anticorps (Atto 488)

N° du produit ABIN5564289

L’anticorps Human Monoclonal anti-Myosin 9 a été validé pour ICC. Il convient pour détecter Myosin 9 dans des échantillons de Humain, Souris, Rat et Drosophila melanogaster.

Aperçu rapide pour Recombinant Myosin 9 anticorps (Atto 488) (ABIN5564289)

Antigène: Myosin 9 (MYH9)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain, Souris, Rat, Drosophila melanogaster

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp Myosin 9 est conjugé à/à la Atto 488

Application: Immunocytochemistry (ICC)

Clone: SF9

Détail du produit anti-Myosin 9 anticorps (Atto 488)

Specificité: Recognizes human, mouse, rat and drosophila myosin IIA (heavy chain).

Réactivité croisée: Mouche des fruits (Drosophila melanogaster), Humain, Souris, Rat (Rattus)

Pureté: >95 % (SDS-PAGE)

Immunogène: Full length myosin IIA from rat liver.

Isotype: IgG2

Information d'application

Commentaires:

anti-Myosin IIA (non-muscle), monoclonal antibody (recombinant) (SF9) (ATTO 488) is composed of human variable regions (VH and VL) (lambda-chain) of immunoglobulin fused to the human lgG2 Fc domain and labeled with ATTO 488.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: In PBS containing 10 % glycerol and 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: Short Term Storage: +4°C
Long Term Storage: +4°C
Keep conjugated formats at +4°C.

Détails sur Myosin 9

Antigène: Myosin 9 (MYH9)

Autre désignation: Myosin IIA

Sujet: Anti-Myosin IIA (non-muscle), monoclonal antibody (recombinant) (SF9) is an antibody developed by antibody phage display technology using a human naive antibody gene library. These libraries consist of scFv (single chain fragment variable) composed of VH (variable domain of the human immunoglobulin heavy chain) and VL (variable domain of the human immunoglobulin light chain) connected by a polypeptide linker. The antibody fragments are displayed on the surface of filamentous bacteriophage (M13). This scFv was selected by affinity selection on antigen in a process termed panning. Multiple rounds of panning are performed to enrich for antigen-specific scFv-phage. Monoclonal antibodies are subsequently identified by screening after each round of selection. The selected monoclonal scFv is cloned into an appropriate vector containing a Fc portion of interest and then produced in mammalian cells to generate an IgG like scFv-Fc fusion protein.

UniProt: P35579

Pathways: Regulation of G-Protein Coupled Receptor Protein Signaling, Integrin Complex